Pear Therapeutics Inc (PEAR) Financials

$0.01

$0.00 (-15.38%)

As on 20-Jun-2023 09:30EDT

Market cap

$4 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

--

P/B Ratio

4.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	12.69	4.21	9.38	32.56	--	--
Cost of Revenue	8.18	5.23	1.72	1.00	--	--
Gross Profit	4.51	-1.03	7.67	31.56	--	--
Operating Expenses	127.86	104.66	84.31	63.17	--	--
Operating Profit (EBIT)	-123.35	-105.69	-76.64	-31.60	--	--
Other Income	--	40.54	--	--	--	--
Profit before Tax	-75.49	-65.14	-97.02	-9.33	--	--
Provision for Tax	-51.75	-89.54	18.82	-42.58	--	--
Profit after Tax (Net Income)	-23.74	24.39	-115.84	33.25	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-65.14	-108.08	-9.33	--	--

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	30.59	90.43	-182.31	-66.04	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	15.10	59.56	273.99	158.63	--	--
Current Liabilities	49.44	47.17	40.69	17.10	--	--
Total Liabilities	95.13	197.16	132.37	109.69	--	--

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	22.17	11.92	6.31	2.71	--	--
Current Assets	72.96	185.24	126.06	106.98	--	--
Total Assets	95.13	197.16	132.37	109.69	--	--
Total Debt*	37.61	27.67	26.35	15.16	--	--
Net Current Assets	23.52	138.08	85.37	89.88	--	--

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-113.90	-109.04	-67.89	-36.60	--	--
Cash Flow from Investing Activities	--	2.88	58.93	-40.56	--	--
Cash from Financing Activities	2.16	164.08	91.70	12.66	--	--
Net Cash Inflow / Outflow	--	57.92	--	--	--	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-25.49	-128.86	112.01	--	--	--
ROE (%)	-39.23	-53.10	93.29	--	--	--
ROA (%)	-16.24	14.80	-95.71	--	--	--
EBIT Margin (%)	-971.72	-2,511.53	-816.75	-97.05	--	--
Net Margin (%)	-187.02	54.51	-1,234.42	102.10	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	2.02	-0.55	-0.71	--	--	--
EBIT Growth (%)	-16.71	-37.89	-142.52	--	--	--
Net Profit Growth (%)	-197.32	121.06	-448.44	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	0.96	--	--	--	--
Close Price ($)	1.18	6.20	--	--	--	--
High Price ($)	10.12	14.60	--	--	--	--
Low Price ($)	0.98	4.85	--	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	1.23	0.31	-0.14	-0.23	--	--
Short term debt to equity ratio	0.96	0.30	-0.14	-0.07	--	--
Current Ratio	1.48	3.93	3.10	6.26	--	--
Quick Ratio	1.47	--	--	--	--	--
Interest Coverage	-31.69	-25.50	-29.92	--	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	54.70	42.63	2.74	3.10	--	--
Asset Turnover	0.09	0.03	0.08	--	--	--
Receivable days	125.70	89.01	24.62	11.31	--	--
Inventory Days	3.08	--	--	--	--	--
Payable days	113.14	220.28	765.58	986.69	--	--
Cash Conversion Cycle	15.64	--	--	--	--	--